Patents by Inventor Scott Gibson LAMONT

Scott Gibson LAMONT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tetracyclic heteroaryl compounds
    Patent number: 11407765
    Abstract: The specification relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof. The specification also relates to processes and intermediates used for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.
    Type: Grant
    Filed: May 7, 2019
    Date of Patent: August 9, 2022
    Assignee: AstraZeneca, AB
    Inventors: Jason Grant Kettle, Sharanjeet Kaur Bagal, Andrew John Eatherton, Shaun Michael Fillery, Graeme Richard Robb, Scott Gibson Lamont, Paul David Kemmitt, Frederick Woolf Goldberg
  • TETRACYCLIC HETEROARYL COMPOUNDS
    Publication number: 20210221823
    Abstract: The specification relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof. The specification also relates to processes and intermediates used for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.
    Type: Application
    Filed: May 7, 2019
    Publication date: July 22, 2021
    Inventors: Jason Grant KETTLE, Sharanjeet Kaur BAGAL, Andrew John EATHERTON, Shaun Michael FILLERY, Graeme Richard ROBB, Scott Gibson LAMONT, Paul David KEMMITT, Frederick Woolf GOLDBERG